Literature DB >> 8459046

Method for grading breast cancer.

E W Elston, I O Ellis.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8459046      PMCID： PMC501162          DOI： 10.1136/jcp.46.2.189-b

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

1.  Simplified method of grading primary carcinomas of the breast.

Authors:  D M Parham; N Hagen; R A Brown
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

2.  Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up.

Authors:  I O Ellis; M Galea; N Broughton; A Locker; R W Blamey; C W Elston
Journal:  Histopathology       Date:  1992-06       Impact factor: 5.087

3.  The pathological classification of human mammary carcinoma: past, present and future.

Authors:  P P Rosen
Journal:  Ann Clin Lab Sci       Date:  1979 Mar-Apr       Impact factor: 1.256

4.  Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure.

Authors:  E R Fisher; R Sass; B Fisher
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

5.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

6.  Confirmation of a prognostic index in primary breast cancer.

Authors:  J H Todd; C Dowle; M R Williams; C W Elston; I O Ellis; C P Hinton; R W Blamey; J L Haybittle
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

7.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640
  7 in total
  57 in total

1.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Authors:  Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Rob Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

2.  Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.

Authors:  Aurelia Vattai; Elif Akyol; Christina Kuhn; Simone Hofmann; Helene Heidegger; Franz von Koch; Kerstin Hermelink; Rachel Wuerstlein; Nadia Harbeck; Doris Mayr; Christine Spitzweg; Bettina Toth; Sven Mahner; Udo Jeschke; Nina Ditsch
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-13       Impact factor: 4.553

3.  21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.

Authors:  Eleftherios P Mamounas; Gong Tang; Soonmyung Paik; Frederick L Baehner; Qing Liu; Jong-Hyeon Jeong; S Rim Kim; Steven M Butler; Farid Jamshidian; Diana B Cherbavaz; Amy P Sing; Steven Shak; Thomas B Julian; Barry C Lembersky; D Lawrence Wickerham; Joseph P Costantino; Norman Wolmark
Journal:  Breast Cancer Res Treat       Date:  2017-11-11       Impact factor: 4.872

4.  The expression of β-catenin in different subtypes of breast cancer and its clinical significance.

Authors:  Shuguang Li; Shanshan Li; Ying Sun; Li Li
Journal:  Tumour Biol       Date:  2014-05-08

5.  NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.

Authors:  Yi-Ping Fu; Hege Edvardsen; Alpana Kaushiva; Juan P Arhancet; Tiffany M Howe; Indu Kohaar; Patricia Porter-Gill; Anushi Shah; Hege Landmark-Høyvik; Sophie D Fosså; Stefan Ambs; Bjørn Naume; Anne-Lise Børresen-Dale; Vessela N Kristensen; Ludmila Prokunina-Olsson
Journal:  Mol Cancer       Date:  2010-05-19       Impact factor: 27.401

6.  Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype.

Authors:  G Kristiansen; M Rose; C Geisler; F R Fritzsche; J Gerhardt; C Lüke; A-M Ladhoff; R Knüchel; M Dietel; H Moch; Z Varga; J-P Theurillat; T A Gorr; E Dahl
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

7.  Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events.

Authors:  Carolin Bock; Christina Kuhn; Nina Ditsch; Regina Krebold; Sabine Heublein; Doris Mayr; Sophie Doisneau-Sixou; Udo Jeschke
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-25       Impact factor: 4.553

8.  Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.

Authors:  Sebastian F Schoppmann; Guenther Bayer; Klaus Aumayr; Susanne Taucher; Silvana Geleff; Margaretha Rudas; Ernst Kubista; Hubert Hausmaninger; Hellmut Samonigg; Michael Gnant; Raimund Jakesz; Reinhard Horvat
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma.

Authors:  Nina Ditsch; Doris Mayr; Miriam Lenhard; Carolin Strauss; Andrea Vodermaier; Julia Gallwas; Doris Stoeckl; Monika Graeser; Tobias Weissenbacher; Klaus Friese; Udo Jeschke
Journal:  Oncol Lett       Date:  2012-07-13       Impact factor: 2.967

10.  Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.

Authors:  Frank Wiesmann; Jürgen Veeck; Oliver Galm; Arndt Hartmann; Manel Esteller; Ruth Knüchel; Edgar Dahl
Journal:  Breast Cancer Res       Date:  2009-06-15       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.